Halcinonide (Dermalog)

05/01/1982 - "The use of 0.1 percent halcinonide cream in the treatment of psoriasis."
01/01/1978 - "Both preparations were well tolerated and side-effects were noted in only 1 patient with psoriasis whose condition was aggravated by halcinonide. "
01/01/1976 - "However, while numerical superiority of good responses to the halcinonide combination was recorded in psoriasis, no statistical significance could be derived due to the limited number of cases. "
01/01/1976 - "The number of excellent responses to therapy showed the halcinonide combination to be significantly superior (p less than 0-01) to the control cream in all diagnostic categories if considered collectively, and in psoriasis if the responses were grouped according to diagnosis. "
11/01/1981 - "In a simultaneously conducted study once daily application of 0.1% halcinonide was compared to the cream base alone (placebo) in 48 patients with atopic dermatitis and 78 with psoriasis. "

04/01/1981 - "The efficacy of halcinonide cream, 0.1 percent, was evaluated in 101 patients with moderate or severe dermatoses. "
04/01/1981 - "Efficacy of halcinonide cream, 0.1 percent, in the treatment of moderate and severe dermatoses."
04/01/2011 - "The objectives of this study were to determine the efficacy and patient acceptance of halcinonide in 216g jars for the treatment of large-area dermatoses. "
04/01/2011 - "Halcinonide 0.1% cream in 216g jars is effective and convenient for patients with large-area dermatoses."
08/01/1982 - "Evaluation of a new halcinonide formulation in the treatment of common dermatoses."

05/01/1992 - "The purpose of this investigation was to find out whether the new Dermalog system could be used in conjunction with dermatoglyphics in patients with atopic dermatitis. "
01/01/1981 - "Seventy-nine patients with atopic dermatitis were treated in a double-blind paired comparison fashion with halcinonide cream (0.025%) or its placebo control. "
01/01/1981 - "Low concentration halcinonide cream in the topical management of atopic dermatitis in pediatric patients."
11/01/1981 - "In a simultaneously conducted study once daily application of 0.1% halcinonide was compared to the cream base alone (placebo) in 48 patients with atopic dermatitis and 78 with psoriasis. "
05/01/1980 - "In a double-blind multi-centre study, comprising ninety-five patients with psoriasis and atopic dermatitis, 0.1% halcinonide cream applied once daily was equally as effective as the cream applied three times daily. "

09/01/1993 - "For pregnant women beyond 35 years the detection rate of Down's syndrome can even be raised to 95-100% by a combination of the Alpha or Dermalog program with the Ulm Index, without entailling an increase in the rate of false-positive results."
05/01/1992 - "For those aged 35 years or greater, however, the Dermalog programme was able to detect 94.4% and the Alpha programme 88.2% of fetuses affected by trisomy 21, with a false-positive rate of 19.6 and 19.1%, respectively. "

08/01/1984 - "Thirty-three patients with acute or subacute eczematous dermatitis were treated for two weeks in a double-blind, parallel-group study to compare the efficacy and cosmetic acceptability of 0.1 percent amcinonide cream and 0.1 percent halcinonide cream. "
08/01/1984 - "A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis."
10/01/1981 - "A 2-week, double-blind clinical trial was conducted to compare the efficacy and cosmetic acceptability of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of 29 patients with eczematous dermatitis. "
10/01/1981 - "A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis."
11/01/2023 - "The therapeutic benefits of halcinonide have rendered it an effective treatment regimen for various dermatological conditions such as psoriasis, dermatitis, and eczema. "